v3.26.3
SCHEDULE OF OTHER RECEIVABLE (Details) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Other Receivables    
Loan receivable [1] $ 14,355,283
Proceeds receivable from sale of subsidiary [2] 2,493,341 2,416,086
Other 1,287 559
Other receivables $ 2,494,628 $ 16,771,928
[1] During the year ended December 31, 2025, the Company entered into five borrowing arrangements with a third party for an aggregate principal amount of $14,160,101, bearing interest at 9% per annum. Certain borrowings were guaranteed by individuals or entities or secured by certain assets. As of June 30, 2026, all of the above borrowings, including the related accrued interest, had been fully repaid.
[2] The amount represents the receivable from the sale of SYCI, which is due in December 2026 from Shandong Rongyuan Pharmaceutical Co., Ltd.